June 30, 2025

Sentara Creates Advanced Cardiac Imaging Team

Sentara's robust cardiovascular program continues to grow in expertise and technological improvements. One of the most recent additions is the Advanced Cardiac Imaging Team (ACIT).

Sentara

June 30, 2025

A Second Glance

An international research team challenges the main hypothesis regarding the evolution of human eye appearance

The Ophthalmologist

June 30, 2025

Predictive Biomarker Under Study in Colorectal Cancer

Researchers have uncovered a biomarker that may determine response to cell therapy and survival in patients with colorectal cancer.

The ASCO Post

June 30, 2025

Updated Results Confirm Benefit of Combination Regimen in BRAFV600E–Mutated Metastatic Colorectal Cancer

Patients with previously untreated BRAF V600E–mutated metastatic colorectal cancer who receive the BRAF inhibitor encorafenib and the EGFR inhibitor cetuximab plus mFOLFOX6 (modified leucovorin, fluor...

The ASCO Post

June 30, 2025

Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer

For the adjuvant treatment of stage III colon cancer with DNA mismatch repair–deficient (dMMR) tumors, the addition of the checkpoint inhibitor atezolizumab to standard chemotherapy significantly impr...

The ASCO Post

June 27, 2025

Best Practice Recommendations for Clinical Homologous Recombination Deficiency Testing

The Association for Molecular Pathology has introduced best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency testing.

The ASCO Post

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 27, 2025

New Guidance Targets Risk-Based Diabetes Care

A new review outlines updated strategies for diagnosing and managing type 2 diabetes, recommending earlier use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with cardiovascular or kidney conditions.

Conexiant

June 26, 2025

GPC3-Targeted ImmunoPET Helps Detect Earlier-Stage Hepatocellular Carcinoma

A novel immunoPET imaging agent targeting GPC3 demonstrated high sensitivity and specificity in detecting GPC3-positive hepatocellular carcinoma (HCC) tumors, according to the results of a pilot clini...

The ASCO Post